Skip to main content
. 2018 Nov;26(11):1461–1473. doi: 10.1016/j.joca.2018.07.013
Descriptive
OR (95% CI)
Total Stable/improved Worsened Crude Age, gender, BMI-adjusted
N 2396 1738 658
Central risk factors
Widespread pain, n (%) 794 (33.14) 561 (32.28) 233 (35.41) 1.15 (0.95; 1.39) 1.11 (0.92; 1.35)
HADS anxiety score ≥8, n (%) 900 (37.56) 642 (36.94) 258 (39.21) 1.10 (0.92; 1.32) 1.09 (0.90; 1.31)
HADS depression score ≥8, n (%) 551 (23.00) 398 (22.90) 153 (23.25) 1.02 (0.82; 1.26) 1.00 (0.80; 1.24)
PCS in the highest tertile (≥9), n (%) 998 (41.65) 722 (41.54) 276 (41.95) 1.02 (0.85; 1.22) 1.01 (0.84; 1.22)
mPDQ ≥ 19, n (%) 202 (8.43) 160 (9.21) 42 (6.38) 0.67 (0.47; 0.96) 0.63 (0.44; 0.91)
ICOAP intermittent in the highest tertile (≥7), n (%) 826 (34.47) 616 (35.44) 210 (31.91) 0.85 (0.71; 1.03) 0.81 (0.66; 0.99)
ICOAP constant in the highest tertile (≥7), n (%) 788 (32.89) 584 (33.60) 204 (31.00) 0.89 (0.73; 1.08) 0.82 (0.67; 1.00)
Peripheral risk factors
Significant injury at baseline, n (%) 706 (29.47) 497 (29.30) 209 (32.45) 1.16 (0.95; 1.41) 1.18 (0.96; 1.44)
Significant injury in the past 12 months, n (%) 63 (2.63) 40 (2.31) 23 (3.51) 1.54 (0.91; 2.59) 1.43 (0.84; 2.44)
Early varus malalignment, n (%) 102 (4.26) 76 (4.73) 26 (4.32) 0.91 (0.58; 1.43) 0.89 (0.56; 1.42)
Early valgus malalignment, n (%) 59 (2.46) 42 (2.66) 17 (2.85) 1.08 (0.61; 1.91) 1.02 (0.57; 1.85)
Varus malalignment, n (%) 61 (2.55) 48 (2.89) 13 (2.08) 0.71 (0.38; 1.32) 0.66 (0.35; 1.27)
Valgus malalignment, n (%) 68 (2.84) 52 (3.13) 16 (2.56) 0.81 (0.46; 1.43) 0.80 (0.45; 1.43)
High risk occupation, n (%) 1093 (45.62) 764 (43.96) 329 (50.00) 1.27 (1.07; 1.53) 1.30 (1.07; 1.56)
2D4D ratio (type 3), n (%) 1188 (49.58) 854 (51.66) 334 (53.96) 1.10 (0.91; 1.32) 1.11 (0.92; 1.34)
Other risk factors
Age (years), mean (SD) 62.41 (10.02) 62.48 (9.96) 62.22 (10.20) 1.00 (0.99; 1.01) 1.00 (0.99; 1.01)
Women, n (%) 1397 (58.31) 997 (57.36) 400 (60.79) 1.15 (0.96; 1.38) 1.15 (0.96; 1.39)
BMI (kg/m2), mean (SD)§ 28.29 (5.80) 28.21 (5.62) 28.50 (6.25) 1.01 (0.99; 1.02) 1.01 (0.99; 1.02)
Nodal OA, n (%) 364 (15.19) 248 (14.87) 116 (18.71) 1.32 (1.03; 1.68) 1.34 (1.04; 1.72)
N of comorbidities, mean (SD), n (%) 0.90 (0.90) 0.90 (0.91) 0.89 (0.86) 0.98 (0.89; 1.09) 0.95 (0.85; 1.06)
Any comorbidities, n (%) 1461 (60.98) 1053 (60.59) 408 (62.01) 1.06 (0.88; 1.28) 1.05 (0.86; 1.28)
Any comorbidities ≥ 2, n (%) 553 (23.08) 407 (23.42) 146 (22.19) 0.93 (0.75; 1.16) 0.88 (0.70; 1.10)
Any comorbidities ≥ 3, n (%) 127 (5.30) 99 (5.70) 28 (4.26) 0.74 (0.48; 1.13) 0.66 (0.42; 1.03)
Any comorbidities ≥ 4, n (%) 14 (0.58) 11 (0.63) 3 (0.46) 0.72 (0.20; 2.59) 0.46 (0.10; 2.07)

In bold - If a 95% confidence interval does not include the null value (i.e. there is a statistically meaningful or statistically significant difference between the groups).

Abbreviations: BMI - body mass index; KP – knee pain; OR – odds ratio; CI –confidence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing Scale; SD – standard deviation; mPDQ – modified Pain Detect Questionnaire; ICOAP - Measure of Intermittent and Constant Osteoarthritis Pain.

A significant change from baseline was calculated using he least significant criterion (LSC) (Nguyen and Eisman, 2000, Wang et al., 2016).

Adjusted for gender and BMI only.

adjuSted for age and BMI only.

§

Adjusted for age and gender only.